Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026)

Capricor Therapeutics (CAPR) posted quarterly Other Non Operating Income of -$72998.0 for Q1 2026, up 47.17% year-over-year from -$49599.5 in Q1 2025, and up 47.17% quarter-over-quarter from -$138188.0 in Q1 2025.

Capricor Therapeutics (CAPR) Other Non Operating Income (2010 - 2026) Analysis & Trends

Capricor Therapeutics' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$72998.0 for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 47.17% year-over-year to -$72998.0; the TTM figure through Mar 2026 stood at $118711.0 (up 33.14% YoY), while the FY2025 annual figure was $399695.0, down 34.74% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$72998.0, up from -$138188.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was -$72998.0 in Q1 2026, with the low at -$138188.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Capricor Therapeutics 383.47 Mn 383.47 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -72,998.00
Mar 31, 2025 -138,188.00
Jun 30, 2021 318,160.00
Sep 30, 2013 11,737.00
Jun 30, 2013 -102,545.00
Mar 31, 2013 -144,705.00
Dec 31, 2012 117,466.00
Sep 30, 2012 9,771.00
Jun 30, 2012 420,890.00
Mar 31, 2012 -2,250.00
Dec 31, 2011 -513.00
Sep 30, 2011 10,411.00
Jun 30, 2011 -1,341.00
Mar 31, 2011 -168.00
Dec 31, 2010 244,478.00
Sep 30, 2010 -2,711.00
Jun 30, 2010 -40.00